Intelligent Bio Solutions Inc【INBS】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 8-K - Current report

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Interference Study designed to validate system specificity in the presence of potentially interfering...

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66...

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances...

👍️0

timberwolf7 4月前

Harry

Looks like you got the 'gift' your 'group' was waiting for.

And whats interesting is, the # of shares I added today were
9% of the shares in total, traded today..

👍️0

timberwolf7 4月前

OK, so WHY the takedown today?? Was is:
-someone found something out with respect to the trial data?
-just a continuation of the flushing out of folks who are saying, enough
of the losses ? Or
-a takedown by those taking advantage of a weak chart, to get cheap shares
in anticipation of the trial data expected by the end of the month?

Hard to believe they will screw up their trial for the 3rd time, so going with the
someone wanted cheap shares. Now I don't expect their development to compete
on an equal basis with a urinalysis test. But do expect it will do what they way its
capable of (detect some drugs, used RECENTLY vs a urinalysis test). And for some?
That will be good enough.

So as a disclaimer: added shares just now. With a market cap of just $6.2 Million or so
at the moment? Easy to see them getting a market cap of say $15-20 Million IF approved
by the fda... 3x the current share price..

👍️0

timberwolf7 4月前

iNBS share price wrestling with its short term moving average line.

The MA line has a slight negative trend to it, the share price appears to be
trying to hold this level. Sets up a confrontation to see if the share price can
resist the pressure of the MA line trying to 'push it lower'. If it does?

Then the MA line shifts into a 'support role' as it tends to slowly roll from negative
to neutral. WHich helps 'carry' the share price hopefully higher the longer the share price
can stay above the MA line.

Or at least that is what I am used to seeing in a 'bottoming' pattern. If it doesn't push back over
because of 'support' for the shares? Well, who knows how low it could go next.

Good luck

👍️0

timberwolf7 4月前

Brutal day for the bio sector (XBI, IBB, LABD)

Oh well, its all going to hinge on what they current
round of trial data 'says' doesn't it.

We hear ya, my group thinks its going lower we’l see but we watching this one, we waited on immx to get under 2 an now its a 4x, same with sla under 2 an steadily moving up over 5

👍️0

timberwolf7 4月前

With INBS saying data analysis by the end of the month?

The heavy sell off from $21 (post the r/split)...

I was thinking the same thing when it dipped below $4.

There was a heck of a VOLUME day on the 26th of Feb. That is 'oft'
seen as a 'signal' that the downtrend may have run its course. Not saying
it can't go lower if no buyers show up. But you get that much churn in one day
and it tends to signal those 'shorting/selling' may have at least covered.

So will see, but at this price level, the low share count, low market cap?
Decided I SHOULD end up being happy with the prices I just paid.

That is IF they get approved and don't have to dilute much more. (smile)

👍️0

harry crumb 4月前

Wont touch this until maybe 3.50 area $$$$$$Then boom!

👍️0

timberwolf7 4月前

Last buy pre data analysis this morn

target goal IF the data is accepted?

$9+ on the share price due to the low market cap, low
share count

disclaimer: own shares, wouldn't be upset if it got to $20/sh

👍️0

timberwolf7 4月前

210 shares 'sold'?? in the pre market was enough to cause
an almost 10% dip to $4.02..

Guess it will be time to add some more IF it stays this low.. on the open..

👍️0

timberwolf7 4月前

Couple of rounds of buys completed sub $4.60

But don't expect this to do much until/IF the fda accepts
their next NDA effort.

And not expecting approval till around the end of the year at the
earliest.

disclaimer; these couple of rounds of buys are purely based on how
far its fallen vs a potential target price. Only looking for $5+ IF their
NDA is accepted, so figured they could support a market cap of $20
Mil if approved (be really nice IF they would stop selling shares (current
share count already up to 1.6 Mil (60% or so) from the 900,000
level post the r/split.

👍️0

timberwolf7 4月前

Hard to believe its gotten this 'cheap' now...

At some point, they will give enough data to the fda,
be able to PROVE the testing has some level of
ACCURACY. At least enough to be able to be confirmed
for some degree of drug testing acceptable for the ones
using it.

I doubt it will ever replace the urinalysis testing for high end
security related positions (I did a few of these over my career,
just the threat of a 'random' test is what kept many who wanted
to keep their jobs 'in-line' if you get my drift.

So the question is, how big a % of those that need periodic/random
testing will this be deemed 'acceptable' for. With the bigger question being,
can it cover the DRUGS of concern. Cause if for instance, it can't detect
something like meth, or synthetics and those that are subject to possibly being
tested finding this out?

Disclaimer: don't own any myself at this point, but been following it because
someone else bought shares at a 'much' higher price. And the reason I didn't buy
into it was I didn't like that they tried to get by with as little trial data, didn't like the
'accuracy' claim that 95% (if I got the number right) was 'good enough'.
So told this individual they would be doing more trials and why. So now the
question is, will their 'accuracy' claim and 'range of detection' be good enough
to get approved for at least 'some' sector of the population??
But at least the share price is now so cheap? But even now, buy a few thousand
shares and one could see that still wiped out. Hmmm to buy or not to buy, that
is the question.. But on the plus side, maybe getting their heads handed to them a
couple of times by the fda finally made them realize trying to 'get by' was not the
right approach to take.

Covering at 6$, not sure this will see 5$, low share count but they are slready diluting it an stealing the longs money from the 1/10 rs, how this is allowed to beyond me an needs to be stopped, the sec is crooked to, allowing such nonsense as this

👍️0

timberwolf7 5月前

Been following this one for over a year now after
someone bought some and is now down around 50%
on their buy in.

And over that year? Liked from the beginning what they
are trying to accomplish, but wasn't enamored with the 'trials' they
had done (too few in my books to confirm the accuracy) Proved to
be a good 'caution' on my part. Also as someone who could have
been subject to a periodic test (security clearance related), the 95%
accuracy claim just wasn't good enough.

But now? IF they can get the fdas approval? With UP TO a 99%
accuracy as they are claiming in their Dec investor deck? And post the
1-10 r/split? Market cap of less than 10 Mil? This is looking quite
tempting. Note, I told my friend to sell his shares when the share price
popped post the r/split, but he didn't. And with the chart saying, its on a
downtrend, with $5 possible if this trend isn't interrupted?
And the new round of trial data?

This has gotten quite tempting. Just keeping an eye on their share count
as they have already sold somewhere around 250-300 thousand shares
since the split

Disclaimer: Own none, but chart watching and hate to say it cause I know
some hold it already. Be nice to see it under $7, $5 would be even better
for a buy in..

👍️0

harry crumb 6月前

Back to reality, mayb hold 5$, shorting turd is money! $$$$$$

👍️0

TrendTrade2016 6月前

First to find them and first to sell em. INBS 😿 I keep selling way too soon on the monster of monsters. Oh boy one day!!!

👍 1

harry crumb 6月前

Let her rip again $$$$$$

👍️0

Zardiw 6月前

$INBS - DDAmanda Chart:

DDAmanda finds these before they run.

Z

👍️0

harry crumb 6月前

Cant believe nobody is here, sold original cost average lots, flipped in/out 4 add. Times today already! $$$$$$, 6 digits baby, what a lst day to 2025! Boom boom bang bang bang! Show us the money!!!!

👍️0

harry crumb 6月前

Boom $$$$$$$, tripled down on the split, average 4, we made loot here!! $$$$$$$

INBS post RS bio beast

👍️0

glenn1919 1年前

INBS.....................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 1年前

INBS............................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 1年前

INBS.........................................................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

Mr Stock pick 1年前

Earnings this week or next
Short squeeze

👍️0

Mr Stock pick 1年前

ZERO shares available to short, no where but up from here

👍️0

The Night Stalker 1年前

epic weekly

👍️0

glenn1919 1年前

INBS................................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

Mr Stock pick 1年前

Hmm a dead board for such a hot stock… where is everybody ? This is about to explode

👍️0

Mr Stock pick 1年前

Low float, 10% short interest, less than a 1000 shares available to short, good news on adding customers and soon good news about FDA approval (more likely to get approved than not) and this will explode with a short squeeze as well

👍️0

glenn1919 2年前

INBS....................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

timberwolf7 2年前

Nov 7th the decision day if my notes are correct.

Chart is hinting that its time for an 'uptick' in the share price

Bit difficult to get a read on its earnings potential, so might play the timeline between
today and Nov 7th, see if it 'gives' a gift..

👍️0

timberwolf7 2年前

So whats the prognosis for INBS?? Got their pending FDA decision day
approaching. Only 4 Mil shares,

👍️0

glens0 2年前

$INBS Somebody bought a lot of shares at day end yesterday. 2 buys after hours 11,956 & 74,984
Here's the post, "https://stocktwits.com/IT_bull/message/587187583

I'm not sure what post you are referencing, but I played this one several times a week or so ago, but haven't been in it since the 19th.

👍️0

peterus 2年前

thought you bought 1.69s lol

👍️0

work-n-hard 2年前

Thanks. Not in at the moment, but will watch. GLTU

👍️0

glens0 2年前

INBS News,
Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Thanet Earth, the UK’s largest greenhouse complex, has adopted its Intelligent Fingerprinting Drug Screening System for in-house drug testing.
“We are thrilled to partner with Intelligent Fingerprinting to enhance our approach to workplace safety,” said Emma Bullock, Head of People at Thanet Earth. “Fingerprint drug testing allows us to ensure that our team is operating in a safe and efficient manner without interrupting our daily operations.”

Thanet Earth is a leader in the UK’s horticultural sector, producing millions of tomatoes, cucumbers, and peppers annually for major retailers nationwide. The company is renowned for its state-of-the-art approach to sustainable farming, integrating cutting-edge technology to optimize yield and environmental impact.

With the implementation of the Intelligent Fingerprinting Drug Screening System, Thanet Earth will be able to conduct workplace drug testing quickly, discreetly, and effectively. This capability is crucial in maintaining safety within the high-paced food production environment, where even minor disruptions can have significant downstream effects.

👍️0

work-n-hard 2年前

INBS: pushing $3M and company touted 10-K this week. (Yr. ending 06-24) Plus watching for competed plan for clinical trial announcement.

👍️0

work-n-hard 2年前

Heading much higher today, even without news/filing.

👍️0

TIMGZ 2年前

BOLLINGER BAND IS THE STRICTEST, VERSATILE INDICATOR ESPECIALLY FOR WHALES.

https://www.google.com/search?q=BOLLINGER+BAND&sourceid=chrome&ie=UTF-8

👍️0

glenn1919 2年前

INBS.............................https://stockcharts.com/h-sc/ui?s=INBS&p=W&b=5&g=0&id=p86431144783

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Intelligent Bio Solutions Inc (INBS)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Intelligent Bio Solutions Inc (INBS) ニュース

Form 8-K - Current report

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 4 - Statement of changes in beneficial ownership of securities

INBS Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Intelligent Bio Solutions Inc (INBS)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

Intelligent Bio Solutions Inc (INBS) ニュース

Form 8-K - Current report

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 4 - Statement of changes in beneficial ownership of securities

INBS Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する